Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. AMZN

Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Denali Therapeutics Inc. (DNLI) PT Lowered to $22 at Stifel

May 8, 2024 6:17 AM EDT

Stifel analyst Paul Mattels lowered the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $22.00 (from $26.00) while maintaining a Hold rating.

The analyst comments "Most importantly, DNLI is noting now that CDER "may be open to discussing an accelerated path" for... More